Inducible cyclooxygenase (COX-2) in glioblastoma - Clinical and immunohistochemical (COX-2 - VEGF) correlations

Clinical Neuropathology

Volumn 25, Issue 2, 2006, Pages 59-66

  Buccoliero, A M ^a   Caldarella, A ^a   Gheri, C F ^a   Taddei, A ^a   Paglierani, M ^a   Pepi, M ^a   Mennonna, P ^b   Taddei, G L ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

COX 2; Glioblastoma; Immunohistochemistry; VEGF

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; TUMOR GROWTH; UPREGULATION;

AGED; BRAIN NEOPLASMS; CYCLOOXYGENASE 2; FEMALE; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33645005152     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bryant CE, Appleton I, Mitchell JA 1998 Vascular endothelial growth factor up-regulates costitutive cyclooxygenase I in primary bovine and human endothelial cells. Life Sci 62: 2195-2201
2. Castelli MG, Chiabrando C, Fanelli R, Martelli L, Butti G, Gaetani P, Paoletti P 1989 Prostaglandin and tromboxane synthesis by human intracranial tumors. Cancer Res 15: 1505-1508
3. Cianchi F, Cortesini C, Bechi P, Fantappi PO, Messerini L, Vannacci A, Sardi I, Baroni G, Boddi V, Mozzanti R, Masini E 2001 Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer. Gastroenterology 121: 1339-1347
4. 2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis. Cancer Res 59: 4574-4577
5. Deininger MH, Weller M, Streffer J, Mittelbronn M, Meyermann R 1999 Patterns of cyclooxygenase-1 and -2 expression in human gliomas in vivo. Acta Neuropathol 98: 240-244
6. Deininger MH, Meyermann R, Trautmann K, Morgalla M, Duffner F, Grote EH, Wickboldt J, Schluesener HJ 2000 Cyclooxygenase (COX) 1-expressing macrophages/microglial cells and COX-2-expressing astrocytes accumulate during oligodendroglioma progression. Brain Res 885: 111-116
7. Fantappiè PO, Masini E, Sardi I, Raimondi L, Bani D, Solazzo M, Vannacci A, Mazzanti R 2002 The MDR phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line. Hepatology 35: 843-852
8. Guddo F, Fontanini G, Reina C, Vignola AM, Angeletti A, Bonsignore G 1999 The expression of basic fibroblast growth factor (bFGF) in tumor-associated stromal cells and vessels is inversely correlated with non-small cell lung cancer progression. Hum Pathol 30: 788-794
9. Joki T, Heese O, Nikas DC, Bello L, Zhang J, Kraeft SK, Seyfried NT, Abe T, Chen LB, Carrol RS, Black PM 2000 Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Cancer Res 60: 4926-4931
10. King JG, Khalili AT 2001 inhibition of human brain tumor cell growth by the anti-inflammatory drug, flurbiprofen. Oncogene 20: 6864-6870
11. Kirkpatrick K, Ogunkolade W, Elkak A, Bustin S, Jenkins P, Ghilchik M, Mokbel K 2002 The mRNA expression of cyclooxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) in human breast cancer. ' Curr Med Res Opin 18: 237-241
12. Koukourakis MI, Giatromanolaki A, O'Byrne KJ, Comley M, Whitehouse RM, Talbot DC, Gatter KC, Harris AL 1997 Platelet-derived endothelial cell growth factor expression correlates with tumor angiogenesis and prognosis in non-small cell lung cancer. Br J Cancer 75: 477-481
13. Kurzel F, Hagel CH, Meissner H, Westphal M, Giese A 2002 Cyclooxygenase inhibitors and tromboxane synthase inhibitors differentially regulate migration arrest, growth inhibition and apoptosis in human glioma. Acta Neurochir (Wien) 144: 71-87
14. 2 regulation of cyclooxygenase expression in keratinocytes is mediated via cyclic nucleotide-linked prostaglandin receptors. J Lip Res 41: 873-881
15. Ohta Y, Shridhar V, Bright RK, Kalemkerian GP, Du W, Carbone M, Watanabe Y, Pass HI 1999 VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours. Br J Cancer 81: 54-61
16. Paoletti P, Chiabrando C, Gaetani P, Castelli MG, Butti G, Martelli L, Rolli M 1989 Prostaglandins in human brain tumors. J Neurosurg Sci 33: 65-69
17. Patel VA, Dunn MJ, Sorokin A 2002 Regulation of MDR-1 (P glycoprotein) by cyclooxygenase-2. J Biol Chem 41: 8915-38920
18. Petersen C, Petersen S, Milas L, Lang FF, Tofilon PJ 2000 Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor. Clin Cancer Res 6: 2513-2520
19. Prayson RA, Castilla EA, Vogelbaum MA, Barnett GH 2002 Cyclooxygenase-2 (COX-2) expression by immunohistochemistry in glioblastoma multiforme. Ann Diagn Pathol 6: 148-153
20. Rao CV, Indranie C, Simi B, Manning PT, Connor JR, Ready BS 2002 Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with colecoxib, a selective cyclooxygenase inhibitor. Cancer Res 62: 165-170
21. Ratnasinghe D, Daschner PJ, Anver MR, Kasprzak BH, Taylor PR, Yeh GC, Tangrea JA 2001 Cyclooxygenase-2, P glycoprotein-170 and drug resistance, is chemoprevention against multidrug resistance possible? Anticancer Res 21: 2141-2147
22. Ready BS, Maruyama H, Kelloff G 1987 Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development. Cancer Res 15: 5341-5346
23. Reddy BS, Tokumo K, Kulkarni N, Aligia C, Kelloff G 1992 Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds. Carcinogenesis 13: 1019-1023
24. Ready BS, Hirose Y, Lubet R, Steele V, Kelloff G, Paulson S, Seibert K, Rao CK 2000 Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. Cancer Res 60: 293-297
25. 2 in human colon cancer cells. Cancer Res 58: 362-366
26. Shono T, Tofilon PJ, Bruner JM, Owolabi O, Lang FF 2001 Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations. Cancer Res 61: 4375-4381
27. 1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer. Prostate 37: 19-29
28. Wilson DE, Anderson KM, Seed TM 1990 Ultrastructural evidence for differentiation in a human glioblastoma cell line treated with inhibitors of eicosanois metabolism. Neurosurgery 27: 523-531